Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

BACKGROUND: Bladder cancer (BLCA) is a common malignant tumor of urinary system with high morbidity and mortality. In recent years, immunotherapy has played a significant role in the treatment of BLCA. Tumor mutation burden (TMB) has been reported to be a powerful biomarker for predicting tumor prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhao, Yu, Yongbo, Zhang, Pengfei, Ma, Guofeng, Zhang, Mingxin, Liang, Ye, Jiao, Wei, Niu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070296/
https://www.ncbi.nlm.nih.gov/pubmed/33894748
http://dx.doi.org/10.1186/s12885-021-08229-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070296/
https://www.ncbi.nlm.nih.gov/pubmed/33894748
http://dx.doi.org/10.1186/s12885-021-08229-1

Ejemplares similares